APO Research

APO RESEARCH · REPORT

Pet Whole Blood and Blood Components

Selected research

Market Analysis & Forecast

Global Pet Whole Blood and Blood Components Market Analysis and Forecast 2026-2032

Market perspective

The global Pet Whole Blood and Blood Components market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pet Whole Blood and Blood Components is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Whole Blood and Blood Components is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Whole Blood and Blood Components is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Whole Blood and Blood Components is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pet Whole Blood and Blood Components include Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe and Lake Immunogenics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pet Whole Blood and Blood Components, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Whole Blood and Blood Components, also provides the sales of main regions and countries. Of the upcoming market potential for Pet Whole Blood and Blood Components, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Whole Blood and Blood Components sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Whole Blood and Blood Components market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pet Whole Blood and Blood Components sales, projected growth trends, production technology, application and end-user industry.

Pet Whole Blood and Blood Components Segment by Company

Thermo Fisher Scientific

Moregate BioTech

Bovogen Biologicals (ANZCO Foods Healthcare)

Pel-Freez, LLC

HemoStat Laboratories

CellSera Australia (Auckland BioSciences)

Animal Technologies

Serana Europe

Lake Immunogenics

MoreCare. Inc.

Nanjing BioChannel Biotechnology Co., Ltd

Pet Whole Blood and Blood Components Segment by Type

Canine

Feline

Bovine

Sheep

Others

Pet Whole Blood and Blood Components Segment by Application

Veterinary Hospital

Clinic

Other

Pet Whole Blood and Blood Components Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Whole Blood and Blood Components market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Whole Blood and Blood Components and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Whole Blood and Blood Components.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pet Whole Blood and Blood Components in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pet Whole Blood and Blood Components manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Whole Blood and Blood Components sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Whole Blood and Blood Components Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Canine Major Manufacturers Table 3. Feline Major Manufacturers Table 4. Bovine Major Manufacturers Table 5. Sheep Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Pet Whole Blood and Blood Components Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Veterinary Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Other Major Manufacturers Table 11. Pet Whole Blood and Blood Components Industry Trends Table 12. Pet Whole Blood and Blood Components Industry Drivers Table 13. Pet Whole Blood and Blood Components Industry Opportunities and Challenges Table 14. Pet Whole Blood and Blood Components Industry Restraints Table 15. Global Pet Whole Blood and Blood Components Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Pet Whole Blood and Blood Components Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Pet Whole Blood and Blood Components Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2021-2026) Table 19. Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2027-2032) Table 20. Global Pet Whole Blood and Blood Components Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kL) Table 21. Global Pet Whole Blood and Blood Components Sales by Region (2021-2026) & (kL) Table 22. Global Pet Whole Blood and Blood Components Sales by Region (2027-2032) & (kL) Table 23. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2021-2026) Table 24. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2027-2032) Table 25. Global Pet Whole Blood and Blood Components Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pet Whole Blood and Blood Components Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Pet Whole Blood and Blood Components Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Pet Whole Blood and Blood Components Sales Market Share by Manufacturers (2021-2026) Table 29. Global Pet Whole Blood and Blood Components Sales Price (USD/L) of Manufacturers (2021-2026) Table 30. Global Pet Whole Blood and Blood Components Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Pet Whole Blood and Blood Components Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Pet Whole Blood and Blood Components Manufacturers, Product Type & Application Table 33. Global Pet Whole Blood and Blood Components Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Pet Whole Blood and Blood Components by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Pet Whole Blood and Blood Components Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pet Whole Blood and Blood Components Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Pet Whole Blood and Blood Components Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2021-2026) Table 40. Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2027-2032) Table 41. Global Pet Whole Blood and Blood Components Sales by Type 2021 VS 2025 VS 2032 (kL) Table 42. Global Pet Whole Blood and Blood Components Sales by Type (2021-2026) & (kL) Table 43. Global Pet Whole Blood and Blood Components Sales by Type (2027-2032) & (kL) Table 44. Global Pet Whole Blood and Blood Components Sales Market Share by Type (2021-2026) Table 45. Global Pet Whole Blood and Blood Components Sales Market Share by Type (2027-2032) Table 46. Global Pet Whole Blood and Blood Components Price by Type (2021-2026) & (USD/L) Table 47. Global Pet Whole Blood and Blood Components Price by Type (2027-2032) & (USD/L) Table 48. Global Pet Whole Blood and Blood Components Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pet Whole Blood and Blood Components Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Pet Whole Blood and Blood Components Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2021-2026) Table 52. Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2027-2032) Table 53. Global Pet Whole Blood and Blood Components Sales by Application 2021 VS 2025 VS 2032 (kL) Table 54. Global Pet Whole Blood and Blood Components Sales by Application (2021-2026) & (kL) Table 55. Global Pet Whole Blood and Blood Components Sales by Application (2027-2032) & (kL) Table 56. Global Pet Whole Blood and Blood Components Sales Market Share by Application (2021-2026) Table 57. Global Pet Whole Blood and Blood Components Sales Market Share by Application (2027-2032) Table 58. Global Pet Whole Blood and Blood Components Price by Application (2021-2026) & (USD/L) Table 59. Global Pet Whole Blood and Blood Components Price by Application (2027-2032) & (USD/L) Table 60. Thermo Fisher Scientific Company Information Table 61. Thermo Fisher Scientific Business Overview Table 62. Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 63. Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio Table 64. Thermo Fisher Scientific Recent Development Table 65. Moregate BioTech Company Information Table 66. Moregate BioTech Business Overview Table 67. Moregate BioTech Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 68. Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio Table 69. Moregate BioTech Recent Development Table 70. Bovogen Biologicals (ANZCO Foods Healthcare) Company Information Table 71. Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview Table 72. Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 73. Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio Table 74. Bovogen Biologicals (ANZCO Foods Healthcare) Recent Development Table 75. Pel-Freez, LLC Company Information Table 76. Pel-Freez, LLC Business Overview Table 77. Pel-Freez, LLC Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 78. Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio Table 79. Pel-Freez, LLC Recent Development Table 80. HemoStat Laboratories Company Information Table 81. HemoStat Laboratories Business Overview Table 82. HemoStat Laboratories Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 83. HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio Table 84. HemoStat Laboratories Recent Development Table 85. CellSera Australia (Auckland BioSciences) Company Information Table 86. CellSera Australia (Auckland BioSciences) Business Overview Table 87. CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 88. CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio Table 89. CellSera Australia (Auckland BioSciences) Recent Development Table 90. Animal Technologies Company Information Table 91. Animal Technologies Business Overview Table 92. Animal Technologies Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 93. Animal Technologies Pet Whole Blood and Blood Components Product Portfolio Table 94. Animal Technologies Recent Development Table 95. Serana Europe Company Information Table 96. Serana Europe Business Overview Table 97. Serana Europe Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 98. Serana Europe Pet Whole Blood and Blood Components Product Portfolio Table 99. Serana Europe Recent Development Table 100. Lake Immunogenics Company Information Table 101. Lake Immunogenics Business Overview Table 102. Lake Immunogenics Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 103. Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio Table 104. Lake Immunogenics Recent Development Table 105. MoreCare. Inc. Company Information Table 106. MoreCare. Inc. Business Overview Table 107. MoreCare. Inc. Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 108. MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio Table 109. MoreCare. Inc. Recent Development Table 110. Nanjing BioChannel Biotechnology Co., Ltd Company Information Table 111. Nanjing BioChannel Biotechnology Co., Ltd Business Overview Table 112. Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 113. Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio Table 114. Nanjing BioChannel Biotechnology Co., Ltd Recent Development Table 115. North America Pet Whole Blood and Blood Components Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Pet Whole Blood and Blood Components Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Pet Whole Blood and Blood Components Sales by Type (2021-2026) & (kL) Table 118. North America Pet Whole Blood and Blood Components Sales by Type (2027-2032) & (kL) Table 119. North America Pet Whole Blood and Blood Components Sales Price by Type (2021-2026) & (USD/L) Table 120. North America Pet Whole Blood and Blood Components Sales Price by Type (2027-2032) & (USD/L) Table 121. North America Pet Whole Blood and Blood Components Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Pet Whole Blood and Blood Components Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Pet Whole Blood and Blood Components Sales by Application (2021-2026) & (kL) Table 124. North America Pet Whole Blood and Blood Components Sales by Application (2027-2032) & (kL) Table 125. North America Pet Whole Blood and Blood Components Sales Price by Application (2021-2026) & (USD/L) Table 126. North America Pet Whole Blood and Blood Components Sales Price by Application (2027-2032) & (USD/L) Table 127. North America Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. North America Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. North America Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 131. North America Pet Whole Blood and Blood Components Sales by Country (2021-2026) & (kL) Table 132. North America Pet Whole Blood and Blood Components Sales by Country (2027-2032) & (kL) Table 133. North America Pet Whole Blood and Blood Components Sales Price by Country (2021-2026) & (USD/L) Table 134. North America Pet Whole Blood and Blood Components Sales Price by Country (2027-2032) & (USD/L) Table 135. United States Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 136. Canada Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 137. Mexico Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 138. Europe Pet Whole Blood and Blood Components Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Pet Whole Blood and Blood Components Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Pet Whole Blood and Blood Components Sales by Type (2021-2026) & (kL) Table 141. Europe Pet Whole Blood and Blood Components Sales by Type (2027-2032) & (kL) Table 142. Europe Pet Whole Blood and Blood Components Sales Price by Type (2021-2026) & (USD/L) Table 143. Europe Pet Whole Blood and Blood Components Sales Price by Type (2027-2032) & (USD/L) Table 144. Europe Pet Whole Blood and Blood Components Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Pet Whole Blood and Blood Components Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Pet Whole Blood and Blood Components Sales by Application (2021-2026) & (kL) Table 147. Europe Pet Whole Blood and Blood Components Sales by Application (2027-2032) & (kL) Table 148. Europe Pet Whole Blood and Blood Components Sales Price by Application (2021-2026) & (USD/L) Table 149. Europe Pet Whole Blood and Blood Components Sales Price by Application (2027-2032) & (USD/L) Table 150. Europe Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 154. Europe Pet Whole Blood and Blood Components Sales by Country (2021-2026) & (kL) Table 155. Europe Pet Whole Blood and Blood Components Sales by Country (2027-2032) & (kL) Table 156. Europe Pet Whole Blood and Blood Components Sales Price by Country (2021-2026) & (USD/L) Table 157. Europe Pet Whole Blood and Blood Components Sales Price by Country (2027-2032) & (USD/L) Table 158. Germany Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 159. France Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 160. U.K. Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 161. Italy Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 162. Russia Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 163. Spain Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 164. Netherlands Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 165. Switzerland Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 166. Sweden Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 167. Poland Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 168. China Pet Whole Blood and Blood Components Revenue by Type (2021-2026) & (US$ Million) Table 169. China Pet Whole Blood and Blood Components Revenue by Type (2027-2032) & (US$ Million) Table 170. China Pet Whole Blood and Blood Components Sales by Type (2021-2026) & (kL) Table 171. China Pet Whole Blood and Blood Components Sales by Type (2027-2032) & (kL) Table 172. China Pet Whole Blood and Blood Components Sales Price by Type (2021-2026) & (USD/L) Table 173. China Pet Whole Blood and Blood Components Sales Price by Type (2027-2032) & (USD/L) Table 174. China Pet Whole Blood and Blood Components Revenue by Application (2021-2026) & (US$ Million) Table 175. China Pet Whole Blood and Blood Components Revenue by Application (2027-2032) & (US$ Million) Table 176. China Pet Whole Blood and Blood Components Sales by Application (2021-2026) & (kL) Table 177. China Pet Whole Blood and Blood Components Sales by Application (2027-2032) & (kL) Table 178. China Pet Whole Blood and Blood Components Sales Price by Application (2021-2026) & (USD/L) Table 179. China Pet Whole Blood and Blood Components Sales Price by Application (2027-2032) & (USD/L) Table 180. Asia Pet Whole Blood and Blood Components Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Pet Whole Blood and Blood Components Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Pet Whole Blood and Blood Components Sales by Type (2021-2026) & (kL) Table 183. Asia Pet Whole Blood and Blood Components Sales by Type (2027-2032) & (kL) Table 184. Asia Pet Whole Blood and Blood Components Sales Price by Type (2021-2026) & (USD/L) Table 185. Asia Pet Whole Blood and Blood Components Sales Price by Type (2027-2032) & (USD/L) Table 186. Asia Pet Whole Blood and Blood Components Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Pet Whole Blood and Blood Components Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Pet Whole Blood and Blood Components Sales by Application (2021-2026) & (kL) Table 189. Asia Pet Whole Blood and Blood Components Sales by Application (2027-2032) & (kL) Table 190. Asia Pet Whole Blood and Blood Components Sales Price by Application (2021-2026) & (USD/L) Table 191. Asia Pet Whole Blood and Blood Components Sales Price by Application (2027-2032) & (USD/L) Table 192. Asia Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 196. Asia Pet Whole Blood and Blood Components Sales by Country (2021-2026) & (kL) Table 197. Asia Pet Whole Blood and Blood Components Sales by Country (2027-2032) & (kL) Table 198. Asia Pet Whole Blood and Blood Components Sales Price by Country (2021-2026) & (USD/L) Table 199. Asia Pet Whole Blood and Blood Components Sales Price by Country (2027-2032) & (USD/L) Table 200. Japan Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 201. South Korea Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 202. India Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 203. Australia Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 204. Taiwan Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Pet Whole Blood and Blood Components Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Pet Whole Blood and Blood Components Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Pet Whole Blood and Blood Components Sales by Type (2021-2026) & (kL) Table 209. SAMEA Pet Whole Blood and Blood Components Sales by Type (2027-2032) & (kL) Table 210. SAMEA Pet Whole Blood and Blood Components Sales Price by Type (2021-2026) & (USD/L) Table 211. SAMEA Pet Whole Blood and Blood Components Sales Price by Type (2027-2032) & (USD/L) Table 212. SAMEA Pet Whole Blood and Blood Components Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Pet Whole Blood and Blood Components Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Pet Whole Blood and Blood Components Sales by Application (2021-2026) & (kL) Table 215. SAMEA Pet Whole Blood and Blood Components Sales by Application (2027-2032) & (kL) Table 216. SAMEA Pet Whole Blood and Blood Components Sales Price by Application (2021-2026) & (USD/L) Table 217. SAMEA Pet Whole Blood and Blood Components Sales Price by Application (2027-2032) & (USD/L) Table 218. SAMEA Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 222. SAMEA Pet Whole Blood and Blood Components Sales by Country (2021-2026) & (kL) Table 223. SAMEA Pet Whole Blood and Blood Components Sales by Country (2027-2032) & (kL) Table 224. SAMEA Pet Whole Blood and Blood Components Sales Price by Country (2021-2026) & (USD/L) Table 225. SAMEA Pet Whole Blood and Blood Components Sales Price by Country (2027-2032) & (USD/L) Table 226. Brazil Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 227. Argentina Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 228. Chile Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 229. Colombia Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 230. Peru Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 232. Israel Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 233. UAE Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 234. Turkey Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 235. Iran Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 236. Egypt Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Pet Whole Blood and Blood Components Distributors List Table 240. Pet Whole Blood and Blood Components Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Pet Whole Blood and Blood Components Image Figure 2. Global Pet Whole Blood and Blood Components Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Whole Blood and Blood Components Market Size Share 2021 VS 2025 VS 2032 Figure 4. Canine Image Figure 5. Feline Image Figure 6. Bovine Image Figure 7. Sheep Image Figure 8. Others Image Figure 9. Global Pet Whole Blood and Blood Components Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Pet Whole Blood and Blood Components Market Size Share 2021 VS 2025 VS 2032 Figure 11. Veterinary Hospital Image Figure 12. Clinic Image Figure 13. Other Image Figure 14. Global Pet Whole Blood and Blood Components Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pet Whole Blood and Blood Components Revenue (2021-2032) & (US$ Million) Figure 16. Global Pet Whole Blood and Blood Components Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Pet Whole Blood and Blood Components Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2021-2032) Figure 19. Global Pet Whole Blood and Blood Components Sales (2021-2032) & (kL) Figure 20. Global Pet Whole Blood and Blood Components Sales by Region: 2021 VS 2025 VS 2032 (kL) Figure 21. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Pet Whole Blood and Blood Components Sales YoY (2021-2032) & (kL) Figure 23. Europe Pet Whole Blood and Blood Components Sales YoY (2021-2032) & (kL) Figure 24. China Pet Whole Blood and Blood Components Sales YoY (2021-2032) & (kL) Figure 25. Asia (Excluding China) Pet Whole Blood and Blood Components Sales YoY (2021-2032) & (kL) Figure 26. South America, Middle East and Africa Pet Whole Blood and Blood Components Sales YoY (2021-2032) & (kL) Figure 27. Global Pet Whole Blood and Blood Components Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Pet Whole Blood and Blood Components Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Pet Whole Blood and Blood Components Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Pet Whole Blood and Blood Components Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2021-2032) Figure 33. Global Pet Whole Blood and Blood Components Sales by Type (2021 VS 2025 VS 2032) & (kL) Figure 34. Global Pet Whole Blood and Blood Components Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Pet Whole Blood and Blood Components Sales Market Share by Type (2021-2032) Figure 36. Global Pet Whole Blood and Blood Components Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Pet Whole Blood and Blood Components Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2021-2032) Figure 39. Global Pet Whole Blood and Blood Components Sales by Application (2021 VS 2025 VS 2032) & (kL) Figure 40. Global Pet Whole Blood and Blood Components Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Pet Whole Blood and Blood Components Sales Market Share by Application (2021-2032) Figure 42. North America Pet Whole Blood and Blood Components Revenue Share by Type (2021-2032) Figure 43. North America Pet Whole Blood and Blood Components Sales Share by Type (2021-2032) Figure 44. North America Pet Whole Blood and Blood Components Revenue Share by Application (2021-2032) Figure 45. North America Pet Whole Blood and Blood Components Sales Share by Application (2021-2032) Figure 46. North America Pet Whole Blood and Blood Components Revenue Share by Country (2021-2032) Figure 47. North America Pet Whole Blood and Blood Components Sales Share by Country (2021-2032) Figure 48. Europe Pet Whole Blood and Blood Components Revenue Share by Type (2021-2032) Figure 49. Europe Pet Whole Blood and Blood Components Sales Share by Type (2021-2032) Figure 50. Europe Pet Whole Blood and Blood Components Revenue Share by Application (2021-2032) Figure 51. Europe Pet Whole Blood and Blood Components Sales Share by Application (2021-2032) Figure 52. Europe Pet Whole Blood and Blood Components Revenue Share by Country (2021-2032) Figure 53. Europe Pet Whole Blood and Blood Components Sales Share by Country (2021-2032) Figure 54. China Pet Whole Blood and Blood Components Revenue Share by Type (2021-2032) Figure 55. China Pet Whole Blood and Blood Components Sales Share by Type (2021-2032) Figure 56. China Pet Whole Blood and Blood Components Revenue Share by Application (2021-2032) Figure 57. China Pet Whole Blood and Blood Components Sales Share by Application (2021-2032) Figure 58. Asia Pet Whole Blood and Blood Components Revenue Share by Type (2021-2032) Figure 59. Asia Pet Whole Blood and Blood Components Sales Share by Type (2021-2032) Figure 60. Asia Pet Whole Blood and Blood Components Revenue Share by Application (2021-2032) Figure 61. Asia Pet Whole Blood and Blood Components Sales Share by Application (2021-2032) Figure 62. Asia Pet Whole Blood and Blood Components Revenue Share by Country (2021-2032) Figure 63. Asia Pet Whole Blood and Blood Components Sales Share by Country (2021-2032) Figure 64. SAMEA Pet Whole Blood and Blood Components Revenue Share by Type (2021-2032) Figure 65. SAMEA Pet Whole Blood and Blood Components Sales Share by Type (2021-2032) Figure 66. SAMEA Pet Whole Blood and Blood Components Revenue Share by Application (2021-2032) Figure 67. SAMEA Pet Whole Blood and Blood Components Sales Share by Application (2021-2032) Figure 68. SAMEA Pet Whole Blood and Blood Components Revenue Share by Country (2021-2032) Figure 69. SAMEA Pet Whole Blood and Blood Components Sales Share by Country (2021-2032) Figure 70. Pet Whole Blood and Blood Components Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Pet Whole Blood and Blood Components Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Canine
  • Feline
  • Bovine
  • Sheep
  • Others
Applications
  • Veterinary Hospital
  • Clinic
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Moregate BioTech
  • Bovogen Biologicals (ANZCO Foods Healthcare)
  • Pel-Freez, LLC
  • HemoStat Laboratories
  • CellSera Australia (Auckland BioSciences)
  • Animal Technologies
  • Serana Europe
  • Lake Immunogenics
  • MoreCare. Inc.
  • Nanjing BioChannel Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Whole Blood and Blood Components Market by Type
  3. 1.2.1 Global Pet Whole Blood and Blood Components Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Canine
  5. 1.2.3 Feline
  6. 1.2.4 Bovine
  7. 1.2.5 Sheep
  8. 1.2.6 Others
  9. 1.3 Pet Whole Blood and Blood Components Market by Application
  10. 1.3.1 Global Pet Whole Blood and Blood Components Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Veterinary Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Pet Whole Blood and Blood Components Market Dynamics
  1. 2.1 Pet Whole Blood and Blood Components Industry Trends
  2. 2.2 Pet Whole Blood and Blood Components Industry Drivers
  3. 2.3 Pet Whole Blood and Blood Components Industry Opportunities and Challenges
  4. 2.4 Pet Whole Blood and Blood Components Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pet Whole Blood and Blood Components Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pet Whole Blood and Blood Components Revenue by Region
  3. 3.2.1 Global Pet Whole Blood and Blood Components Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Whole Blood and Blood Components Revenue by Region (2021-2026)
  5. 3.2.3 Global Pet Whole Blood and Blood Components Revenue by Region (2027-2032)
  6. 3.2.4 Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pet Whole Blood and Blood Components Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pet Whole Blood and Blood Components Sales by Region
  9. 3.4.1 Global Pet Whole Blood and Blood Components Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pet Whole Blood and Blood Components Sales by Region (2021-2026)
  11. 3.4.3 Global Pet Whole Blood and Blood Components Sales by Region (2027-2032)
  12. 3.4.4 Global Pet Whole Blood and Blood Components Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pet Whole Blood and Blood Components Revenue by Manufacturers
  2. 4.1.1 Global Pet Whole Blood and Blood Components Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pet Whole Blood and Blood Components Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pet Whole Blood and Blood Components Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Whole Blood and Blood Components Sales by Manufacturers
  6. 4.2.1 Global Pet Whole Blood and Blood Components Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pet Whole Blood and Blood Components Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pet Whole Blood and Blood Components Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pet Whole Blood and Blood Components Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pet Whole Blood and Blood Components Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pet Whole Blood and Blood Components Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pet Whole Blood and Blood Components Manufacturers, Product Type & Application
  13. 4.7 Global Pet Whole Blood and Blood Components Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pet Whole Blood and Blood Components Market CR5 and HHI
  16. 4.8.2 2025 Pet Whole Blood and Blood Components Tier 1, Tier 2, and Tier 3
5 Pet Whole Blood and Blood Components Market by Type
  1. 5.1 Global Pet Whole Blood and Blood Components Revenue by Type
  2. 5.1.1 Global Pet Whole Blood and Blood Components Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pet Whole Blood and Blood Components Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pet Whole Blood and Blood Components Sales by Type
  6. 5.2.1 Global Pet Whole Blood and Blood Components Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Whole Blood and Blood Components Sales by Type (2021-2032) & (kL)
  8. 5.2.3 Global Pet Whole Blood and Blood Components Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pet Whole Blood and Blood Components Price by Type
6 Pet Whole Blood and Blood Components Market by Application
  1. 6.1 Global Pet Whole Blood and Blood Components Revenue by Application
  2. 6.1.1 Global Pet Whole Blood and Blood Components Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pet Whole Blood and Blood Components Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pet Whole Blood and Blood Components Sales by Application
  6. 6.2.1 Global Pet Whole Blood and Blood Components Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pet Whole Blood and Blood Components Sales by Application (2021-2032) & (kL)
  8. 6.2.3 Global Pet Whole Blood and Blood Components Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pet Whole Blood and Blood Components Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Moregate BioTech
  8. 7.2.1 Moregate BioTech Company Information
  9. 7.2.2 Moregate BioTech Business Overview
  10. 7.2.3 Moregate BioTech Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio
  12. 7.2.5 Moregate BioTech Recent Developments
  13. 7.3 Bovogen Biologicals (ANZCO Foods Healthcare)
  14. 7.3.1 Bovogen Biologicals (ANZCO Foods Healthcare) Company Information
  15. 7.3.2 Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview
  16. 7.3.3 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio
  18. 7.3.5 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments
  19. 7.4 Pel-Freez, LLC
  20. 7.4.1 Pel-Freez, LLC Company Information
  21. 7.4.2 Pel-Freez, LLC Business Overview
  22. 7.4.3 Pel-Freez, LLC Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio
  24. 7.4.5 Pel-Freez, LLC Recent Developments
  25. 7.5 HemoStat Laboratories
  26. 7.5.1 HemoStat Laboratories Company Information
  27. 7.5.2 HemoStat Laboratories Business Overview
  28. 7.5.3 HemoStat Laboratories Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio
  30. 7.5.5 HemoStat Laboratories Recent Developments
  31. 7.6 CellSera Australia (Auckland BioSciences)
  32. 7.6.1 CellSera Australia (Auckland BioSciences) Company Information
  33. 7.6.2 CellSera Australia (Auckland BioSciences) Business Overview
  34. 7.6.3 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio
  36. 7.6.5 CellSera Australia (Auckland BioSciences) Recent Developments
  37. 7.7 Animal Technologies
  38. 7.7.1 Animal Technologies Company Information
  39. 7.7.2 Animal Technologies Business Overview
  40. 7.7.3 Animal Technologies Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Animal Technologies Pet Whole Blood and Blood Components Product Portfolio
  42. 7.7.5 Animal Technologies Recent Developments
  43. 7.8 Serana Europe
  44. 7.8.1 Serana Europe Company Information
  45. 7.8.2 Serana Europe Business Overview
  46. 7.8.3 Serana Europe Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Serana Europe Pet Whole Blood and Blood Components Product Portfolio
  48. 7.8.5 Serana Europe Recent Developments
  49. 7.9 Lake Immunogenics
  50. 7.9.1 Lake Immunogenics Company Information
  51. 7.9.2 Lake Immunogenics Business Overview
  52. 7.9.3 Lake Immunogenics Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio
  54. 7.9.5 Lake Immunogenics Recent Developments
  55. 7.10 MoreCare. Inc.
  56. 7.10.1 MoreCare. Inc. Company Information
  57. 7.10.2 MoreCare. Inc. Business Overview
  58. 7.10.3 MoreCare. Inc. Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio
  60. 7.10.5 MoreCare. Inc. Recent Developments
  61. 7.11 Nanjing BioChannel Biotechnology Co., Ltd
  62. 7.11.1 Nanjing BioChannel Biotechnology Co., Ltd Company Information
  63. 7.11.2 Nanjing BioChannel Biotechnology Co., Ltd Business Overview
  64. 7.11.3 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio
  66. 7.11.5 Nanjing BioChannel Biotechnology Co., Ltd Recent Developments
8 North America
  1. 8.1 North America Pet Whole Blood and Blood Components Market Size by Type
  2. 8.1.1 North America Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
  3. 8.1.2 North America Pet Whole Blood and Blood Components Sales by Type (2021-2032)
  4. 8.1.3 North America Pet Whole Blood and Blood Components Price by Type (2021-2032)
  5. 8.2 North America Pet Whole Blood and Blood Components Market Size by Application
  6. 8.2.1 North America Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
  7. 8.2.2 North America Pet Whole Blood and Blood Components Sales by Application (2021-2032)
  8. 8.2.3 North America Pet Whole Blood and Blood Components Price by Application (2021-2032)
  9. 8.3 North America Pet Whole Blood and Blood Components Market Size by Country
  10. 8.3.1 North America Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pet Whole Blood and Blood Components Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pet Whole Blood and Blood Components Market Size by Type
  2. 9.1.1 Europe Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pet Whole Blood and Blood Components Sales by Type (2021-2032)
  4. 9.1.3 Europe Pet Whole Blood and Blood Components Price by Type (2021-2032)
  5. 9.2 Europe Pet Whole Blood and Blood Components Market Size by Application
  6. 9.2.1 Europe Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pet Whole Blood and Blood Components Sales by Application (2021-2032)
  8. 9.2.3 Europe Pet Whole Blood and Blood Components Price by Application (2021-2032)
  9. 9.3 Europe Pet Whole Blood and Blood Components Market Size by Country
  10. 9.3.1 Europe Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pet Whole Blood and Blood Components Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pet Whole Blood and Blood Components Market Size by Type
  2. 10.1.1 China Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
  3. 10.1.2 China Pet Whole Blood and Blood Components Sales by Type (2021-2032)
  4. 10.1.3 China Pet Whole Blood and Blood Components Price by Type (2021-2032)
  5. 10.2 China Pet Whole Blood and Blood Components Market Size by Application
  6. 10.2.1 China Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
  7. 10.2.2 China Pet Whole Blood and Blood Components Sales by Application (2021-2032)
  8. 10.2.3 China Pet Whole Blood and Blood Components Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Whole Blood and Blood Components Market Size by Type
  2. 11.1.1 Asia Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pet Whole Blood and Blood Components Sales by Type (2021-2032)
  4. 11.1.3 Asia Pet Whole Blood and Blood Components Price by Type (2021-2032)
  5. 11.2 Asia Pet Whole Blood and Blood Components Market Size by Application
  6. 11.2.1 Asia Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pet Whole Blood and Blood Components Sales by Application (2021-2032)
  8. 11.2.3 Asia Pet Whole Blood and Blood Components Price by Application (2021-2032)
  9. 11.3 Asia Pet Whole Blood and Blood Components Market Size by Country
  10. 11.3.1 Asia Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pet Whole Blood and Blood Components Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Whole Blood and Blood Components Market Size by Type
  2. 12.1.1 SAMEA Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pet Whole Blood and Blood Components Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pet Whole Blood and Blood Components Price by Type (2021-2032)
  5. 12.2 SAMEA Pet Whole Blood and Blood Components Market Size by Application
  6. 12.2.1 SAMEA Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pet Whole Blood and Blood Components Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pet Whole Blood and Blood Components Price by Application (2021-2032)
  9. 12.3 SAMEA Pet Whole Blood and Blood Components Market Size by Country
  10. 12.3.1 SAMEA Pet Whole Blood and Blood Components Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pet Whole Blood and Blood Components Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pet Whole Blood and Blood Components Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pet Whole Blood and Blood Components Value Chain Analysis
  2. 13.1.1 Pet Whole Blood and Blood Components Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pet Whole Blood and Blood Components Production Mode & Process
  6. 13.2 Pet Whole Blood and Blood Components Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pet Whole Blood and Blood Components Distributors
  9. 13.2.3 Pet Whole Blood and Blood Components Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research